Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Mario Abinun

Newcastle AuthorsTitleYearFull text
Dr Ina Schim van der Loeff
Dr Mario Abinun
Angela Grainger
Dr Karin Engelhardt
Professor Sophie Hambleton
et al.
Defective neutrophil development and specific granule deficiency caused by a homozygous splice-site mutation in SMARCD22021
Dr Christo Tsilifis
Dr Mary Slatter
Dr Zohreh Nademi
Dr Terence Flood
Professor Andrew Cant
et al.
Hematopoietic Stem Cell Transplantation Resolves the Immune Deficit Associated with STAT3-Dominant-Negative Hyper-IgE Syndrome2021
Dr Alexandra Laberko
Dr Mario Abinun
Professor Roderick Skinner
Professor Andrew Gennery
HSCT is effective in patients with PSTPIP1-associated myeloid-related proteinemia inflammatory (PAMI) syndrome2021
Dr Zohreh Nademi
Dr Su Han Lum
Dr Terence Flood
Dr Mario Abinun
Dr Stephen Owens
et al.
Outcome of Hematopoietic Stem Cell Transplantation in patients with Mendelian Susceptibility to Mycobacterial Diseases2021
Dr Su Han Lum
Dr Zohreh Nademi
Dr Terence Flood
Dr Timothy Cheetham
Dr Mario Abinun
et al.
Outcome of Non-hematological Autoimmunity After Hematopoietic Cell Transplantation in Children with Primary Immunodeficiency2021
Dr Mario Abinun
Pathobiologic Mechanisms of Neurodegeneration in Osteopetrosis Derived From Structural and Functional Analysis of 14 ClC-7 Mutants2021
Dr Mario Abinun
Professor Andrew Gennery
Hematopoietic Stem Cell Transplantation and Vasculopathy Associated With STAT3-Dominant-Negative Hyper-IgE Syndrome2020
Dr Karin Engelhardt
Dr Zohreh Nademi
Dr Saba Habibollah
Dr Aisling Flinn
Dr Ben Shillitoe
et al.
Improved transplant survival and long-term disease outcome in children with MHC class II deficiency2020
Dr Sheila Waugh
Dr Lisa Newton
Dr Zohreh Nademi
Dr Stephen Owens
Professor Marieke Emonts-le Clercq
et al.
Outcome of autoimmune cytopenia after hematopoietic cell transplantation in primary immunodeficiency2020
Mike Cole
Dr Ann Marie Hynes
Denise Howel
Dr Lesley Hall
Dr Mario Abinun
et al.
Adjuvant rituximab, a potential treatment for the young patient with Graves’ hyperthyroidism (RiGD): study protocol for a single-arm, single-stage, phase II trial2019
1234567891011121314151617181920...